Year-over-year net earnings per share growth for the last 12 months: Teleflex Inc. (TFX)
Teleflex Incorporated (TFX) faces pricing pressure from clinics and strict FDA oversight, which impacts its financial stability. The quarterly EPS trend captures these processes, where the 340.60 mark reflects the current state of earnings. Business resilience is supported by a broad portfolio of critical care and surgical equipment, while profit growth is driven by innovations in minimally invasive surgery and new hemostasis systems.
Analytical breakdowns and data insights for company Teleflex Corp (TFX)
- market value and analyst target forecast:
- company stock exchange capitalization indicators:
- book capitalization indicators:
- company total debt and liquidity indicators:
Debt to Equity Teleflex Incorporated|TFX - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Teleflex Incorporated|TFX - Company Cumulative Debt|Debt to Book Capitalization Ratio Teleflex Inc|TFX - Company Long-Term Indebtedness|Company Current Liabilities Teleflex|Quick Liquidity teleflex.com
- earnings and market multiples details:
TFX - Net Financial Result|Future Profit Teleflex Incorporated|TFX - Market Price to Net Income Ratio|Forward P/E Multiple Teleflex Inc|TFX - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Teleflex Inc|TFX - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Teleflex|TFX - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth teleflex.com|TFX - Earnings per share trend in current year|Net earnings per share growth forecast for next year Teleflex Incorporated
Comprehensive company analysis:Teleflex Incorporated
Quarterly EPS growth measures the efficiency of converting macroeconomic recovery into net income per share. For Teleflex Incorporated (TFX), whose innovative catheters are highly valued by intensive care specialists, this metric confirms the monetization of its technological leadership. By analyzing the amplitude of quarterly EPS fluctuations, one can assess the resilience of earnings across different cycles. The current value of 340.60 reflects the real-time yield dynamics. Steady growth in this indicator confirms the fundamental strength of the business.
Key competitors
Intuitive (ISRG) - Year-over-year earnings per share growth for the last twelve months|DHR - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BDX|STE (STERIS Group) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months West Pharmaceutical Services (WST)|BAX (baxter.com) - Year-over-year earnings per one share growth for the last 12 months|Masimo - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Stevanato Group SpA STVN|MMSI - Year-over-year earnings per share growth for the last twelve months|Nobel Biocare (NVST) - Year-over-year net earnings per share growth for the last 12 months|ICUI: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months dentsplysirona.com (XRAY)|Year-over-year earnings per share growth for the last twelve months LeMaitre Vascular|Year-over-year earnings per share growth for the last 12 months ATRC (AtriCure Inc)|Year-over-year net earnings per share growth for the last 12 months STAA (STAAR Surgical Corp)|Year-over-year earnings per share growth rate for the last twelve months NAGE|Year-over-year earnings per share growth for the last twelve months ZimVie Inc. ZIMV|Year-over-year net earnings per share change for the last twelve months angiodynamics.com (ANGO)|CERS: Year-over-year net earnings per share growth for the last 12 months|Alpha Teknova - Year-over-year earnings per share growth rate for the last twelve months|MGRM: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Sharps Technology (STSS)|Year-over-year earnings per share growth for the last twelve months InfuSystem|Year-over-year earnings per share growth for the last twelve months UTMD|Quarterly EPS earnings growth KRMD|NYXH - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth MBOT (Microbot Medical Inc)|PDEX (Pro-Dex Inc.) - Year-over-year net earnings per share trend for the last twelve months|ZTEK - Year-over-year earnings per share growth for the last twelve months|ELUT: Year-over-year earnings per share growth for the last twelve months|MLSS: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months NEXGEL Inc. (NXGL)|Year-over-year net earnings per share growth for the last 12 months RVP|Year-over-year earnings per share growth for the last 12 months HBIO (Harvard Bioscience Inc.)|Year-over-year net earnings per share growth for the last 12 months FEMY (Femasys Inc.)|MHUA (meihuamed.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth POAI (Predictive Oncology Inc.)|Year-over-year net earnings per share change for the last twelve months Callan JMB Inc. (CJMB)|ATRI - Year-over-year earnings per share growth for the last twelve months|NURO (NeuroMetrix Corporation) - Year-over-year earnings per share growth for the last 12 months
